Leiden University Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (40)

2024

  1. International Clinical Practice Guideline Recommendations for Acute Pulmonary Embolism: Harmony, Dissonance, and Silence

    Journal of the American College of Cardiology, Vol. 84, Núm. 16, pp. 1561-1577

  2. Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial

    Thrombosis Research, Vol. 235, pp. 79-87

  3. Risk stratification of acute pulmonary embolism

    Presse Medicale

  4. Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis

    European Heart Journal, Vol. 45, Núm. 32, pp. 2933-2950

  5. Validating International Classification of Diseases Code 10th Revision algorithms for accurate identification of pulmonary embolism

    Journal of Thrombosis and Haemostasis

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial

    Thrombosis and haemostasis, Vol. 123, Núm. 7, pp. 723-733

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. Inhibition of thrombin-activatable fibrinolysis inhibitor via DS-1040 to accelerate clot lysis in patients with acute pulmonary embolism: a randomized phase 1b study

    Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 10, pp. 2929-2940

  5. Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2

    Clinical Research in Cardiology, Vol. 112, Núm. 10, pp. 1372-1381

2022

  1. Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study

    Thrombosis and Haemostasis, Vol. 123, Núm. 6, pp. 649-662

  2. Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes

    European Journal of Internal Medicine, Vol. 103, pp. 76-83

  3. Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial

    Thrombosis and Haemostasis, Vol. 122, Núm. 5, pp. 857-866

2021

  1. Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database

    The Lancet Respiratory Medicine, Vol. 9, Núm. 1, pp. 33-42

  2. Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

    The Lancet Haematology, Vol. 8, Núm. 9, pp. e627-e636

  3. Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial

    JAMA - Journal of the American Medical Association, Vol. 326, Núm. 13, pp. 1277-1285

  4. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  5. Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis

    European heart journal, Vol. 42, Núm. 33, pp. 3190-3199

  6. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: The HOME-PE randomized trial

    European Heart Journal, Vol. 42, Núm. 33, pp. 3146-3157

2020

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

    European Heart Journal, Vol. 41, Núm. 4, pp. 543-603